{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:34:08Z","timestamp":1771684448301,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10157-022-02226-9","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T08:04:31Z","timestamp":1651219471000},"page":"859-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-0951","authenticated-orcid":false,"given":"Minami","family":"Toda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Beppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuiko","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Ishiwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kawanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshie","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutomo","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Wakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"1","key":"2226_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1440-1797.1997.tb00186.x","volume":"3","author":"Y Kobayashi","year":"1997","unstructured":"Kobayashi Y, Kokubo T, Horii A, et al. Prognostic prediction of long-term clinical courses in individual IgA nephropathy patients. Nephrology. 1997;3(1):35\u201340.","journal-title":"Nephrology"},{"key":"2226_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/ajkd.2001.27689","volume":"38","author":"LP Bartosik","year":"2001","unstructured":"Bartosik LP, Lajoie G, Sugar L, et al. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001;38:728\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2226_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/ijms23020727","volume":"23","author":"O Hotta","year":"2022","unstructured":"Hotta O, Ieiri N, Nagai M, Tanaka A, Harabuchi Y. Role of palatine tonsil and epipharyngeal lymphoid tissue in the development of glomerular active lesions (glomerular vasculitis) in immunoglobulin A nephropathy. Int J Mol Sci. 2022;23(2):727.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2226_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/ndt\/gfn610","volume":"24","author":"M Goto","year":"2009","unstructured":"Goto M, Kawamura T, Wakai K, et al. Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm. Nephrol Dial Transplant. 2009;24(4):1242\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"2226_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jama.2011.1141","volume":"306","author":"A Vivante","year":"2011","unstructured":"Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study. JAMA. 2011;306(7):729\u201336.","journal-title":"JAMA"},{"issue":"10","key":"2226_CR6","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1681\/ASN.2017010108","volume":"28","author":"AM Sevillano","year":"2017","unstructured":"Sevillano AM, Gutierrez E, Yuste C, et al. Remission of hematuria improves renal survival in IgA nephropathy. J Am Soc Nephrol. 2017;28(10):3089\u201399.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2226_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.15171\/jnp.2016.12","volume":"5","author":"C Iwasaki","year":"2016","unstructured":"Iwasaki C, Moriyama T, Tanaka K, et al. Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria. J Nephropathol. 2016;5(2):72\u20138.","journal-title":"J Nephropathol"},{"issue":"10","key":"2226_CR8","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1681\/ASN.2012010063","volume":"23","author":"E Guti\u00e9rrez","year":"2012","unstructured":"Guti\u00e9rrez E, Zamora I, Ballar\u00edn JA, et al. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. J Am Soc Nephrol. 2012;23(10):1753\u201360.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2226_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1053\/ajkd.2001.27690","volume":"38","author":"O Hotta","year":"2001","unstructured":"Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38(4):736\u201343.","journal-title":"Am J Kidney Dis"},{"key":"2226_CR10","first-page":"94","volume":"157","author":"M Miyazaki","year":"2007","unstructured":"Miyazaki M, Hotta O, Komatsuda A, et al. Japanese Multicenter Study Group on Treatment of IgA Nephropathy (JST-IgAN): A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy\u2014a 5-year report. Contrib Nephrol. 2007;157:94\u20138.","journal-title":"Contrib Nephrol"},{"key":"2226_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10157-013-0779-7","volume":"17","author":"K Matsuzaki","year":"2013","unstructured":"Matsuzaki K, Suzuki Y, Nakata J, et al. Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol. 2013;17:827\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"2226_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s10157-013-0822-8","volume":"18","author":"D Kamei","year":"2014","unstructured":"Kamei D, Moriyama T, Takei T, et al. Comparison between consecutive and intermittent steroid pulse therapy combined with tonsillectomy for clinical remission of IgA nephropathy. Clin Exp Nephrol. 2014;18:320\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"9156","key":"2226_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi C, Bolasco PG, Fogazzi GB, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353(9156):883\u20137.","journal-title":"Lancet"},{"key":"2226_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12026-016-8859-x","volume":"65","author":"O Hotta","year":"2017","unstructured":"Hotta O, Tanaka A, Torigoe A, et al. Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA). Immunol Res. 2017;65:66\u201371.","journal-title":"Immunol Res"},{"issue":"2","key":"2226_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5301\/jn.5000151","volume":"26","author":"T Kawamura","year":"2013","unstructured":"Kawamura T, Joh K, Okonogi H, et al. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. J Nephrol. 2013;26(2):350\u20137.","journal-title":"J Nephrol"},{"issue":"3","key":"2226_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.semnephrol.2004.01.005","volume":"24","author":"O Hotta","year":"2004","unstructured":"Hotta O. Use of corticosteroids, other immunosuppressive therapies, and tonsillectomy in the treatment of IgA nephropathy. Semin Nephrol. 2004;24(3):244\u201355.","journal-title":"Semin Nephrol"},{"issue":"2","key":"2226_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.xkme.2019.11.003","volume":"2","author":"M Nagai","year":"2020","unstructured":"Nagai M, Saitoh S, Takaki T, et al. Glomerular cellular interactions following disruption of the glomerular basement membrane in IgA nephropathy: ultrastructural analyses by 3-dimensional serial block-face scanning electron microscopy. Kidney Med. 2020;2(2):222\u20135.","journal-title":"Kidney Med."},{"issue":"2","key":"2226_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40620-021-01064-4","volume":"35","author":"M Nagai","year":"2022","unstructured":"Nagai M, Kobayashi K, Izumi N, et al. Pre-treatment hematuria and crescents predict estimated glomerular filtration rate trajectory after methylprednisolone pulse therapy with tonsillectomy for IgA nephropathy. J Nephrol. 2022;35(2):441\u20139.","journal-title":"J Nephrol"},{"key":"2226_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.autrev.2019.06.002","volume":"18","author":"O Hotta","year":"2019","unstructured":"Hotta O, Tanaka A, Oda T. Chronic epipharyngitis: a missing background of IgA nephropathy. Autoimmun Rev. 2019;18:835\u20136.","journal-title":"Autoimmun Rev"},{"key":"2226_CR20","first-page":"167","volume":"24","author":"K Hozawa","year":"2011","unstructured":"Hozawa K, Takahasi E, Adachi M. Effects of residual tonsillar tissue on the IgA nephropathy prognosis. Stomato-Pharyngology. 2011;24:167\u201370.","journal-title":"Stomato-Pharyngology."},{"issue":"23","key":"2226_CR21","doi-asserted-by":"publisher","first-page":"13022","DOI":"10.3390\/ijms222313022","volume":"22","author":"Y Nagasawa","year":"2021","unstructured":"Nagasawa Y, Nomura R, Misaki T, et al. Relationship between IgA nephropathy and Porphyromonas gingivalis; red complex of periodontopathic bacterial sepecies. Int J Mol Sci. 2021;22(23):13022.","journal-title":"Int J Mol Sci"},{"key":"2226_CR22","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.semnephrol.2018.05.020","volume":"38","author":"R Coppo","year":"2018","unstructured":"Coppo R. The gut-renal connection in IgA nephropathy. Semin Nephrol. 2018;38:504\u201312.","journal-title":"Semin Nephrol"},{"key":"2226_CR23","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","volume":"97","author":"P Collin","year":"2002","unstructured":"Collin P, Syrj\u00e4nen J, Partanen J, et al. Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol. 2002;97:2572\u20136.","journal-title":"Am J Gastroenterol"},{"key":"2226_CR24","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/ndt\/gfp133","volume":"24","author":"HK Smerud","year":"2009","unstructured":"Smerud HK, Fellstr\u00f6m B, H\u00e4llgren R, et al. Gluten sensitivity in patients with IgA nephropathy. Nephrol Dial Transplant. 2009;24:2476\u201381.","journal-title":"Nephrol Dial Transplant"},{"key":"2226_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/MCG.0b013e318284792e","volume":"47","author":"A Welander","year":"2013","unstructured":"Welander A, Sundelin B, Fored M, et al. Increased risk of IgA nephropathy among individuals with celiac disease. J Clin Gastroenterol. 2013;47:678\u201383.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"2226_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10157-016-1324-2","volume":"21","author":"Y Hoshino","year":"2017","unstructured":"Hoshino Y, Moriyama T, Uchida K, et al. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients. Clin Exp Nephrol. 2017;21(4):617\u201323.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02226-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-022-02226-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-022-02226-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T04:16:37Z","timestamp":1660709797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-022-02226-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2226"],"URL":"https:\/\/doi.org\/10.1007\/s10157-022-02226-9","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures in this study involving human participants were approved by the Ethics Committee of Tokyo Metropolitan Health and Hospitals Corporation Ohkubo Hospital (approval number: 2021-16) and performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Because this was a retrospective and non-interventional study, we adopted an opt-out method instead of written informed consent. We provided patients with the opportunity to opt out by explaining the purpose of the study and the required individual data for the study by posting on the website of Ohkubo Hospital, 2-44-1 Kabuki-cho, Shinjyuku, Tokyo, Japan.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}